Annual Working Capital
$36.55 M
-$5.93 M-13.96%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual working capital is currently $36.55 million, with the most recent change of -$5.93 million (-13.96%) on 31 December 2023. ZBIO annual working capital is now -13.96% below its all-time high of $42.48 million, reached on 31 December 2022.ZBIO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$349.78 M
+$200.29 M+133.98%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly working capital is currently $349.78 million, with the most recent change of +$200.29 million (+133.98%) on 30 September 2024. Over the past year, it has increased by +$313.24 million (+857.10%). ZBIO quarterly working capital is now at all-time high.ZBIO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +857.1% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.0% | at low | at high | +3632.2% |
| 5 y | 5 years | -14.0% | at low | at high | +3632.2% |
| alltime | all time | -14.0% | at low | at high | +3632.2% |
ProShares UltraPro Short Nasdaq Biotechnology Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $349.78 M(+134.0%) |
| June 2024 | - | $149.49 M(+1495.1%) |
| Mar 2024 | - | $9.37 M(-74.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $36.55 M(-14.0%) | $36.55 M(-40.2%) |
| Sept 2023 | - | $61.12 M |
| Dec 2022 | $42.48 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual working capital?
- What is the all time high annual working capital for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly working capital?
- What is the all time high quarterly working capital for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly working capital year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual working capital?
The current annual working capital of ZBIO is $36.55 M
What is the all time high annual working capital for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual working capital is $42.48 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly working capital?
The current quarterly working capital of ZBIO is $349.78 M
What is the all time high quarterly working capital for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly working capital is $349.78 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly working capital year-on-year change?
Over the past year, ZBIO quarterly working capital has changed by +$313.24 M (+857.10%)